Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Nasdaq: CRBP · Pharmaceutical Preparations · Norwood, MA · filing with the SEC since 2014
Who owns Corbus Pharmaceuticals Holdings, Inc.
As filed with the SECHolders of 5% or more
5
Cormorant Asset Management, LP holds 13.4% of Common Stock, par value $0.0001 per share, as its SCHEDULE 13G/A filed Dec 15, 2025 says.
Directors and officers
12
report now, of 24 people on the record since 2014. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
Cormorant Asset Management, LP
SCHEDULE 13G/A · filed Dec 15, 2025 · Common Stock, par value $0.0001 per share · 12.8% in Nov 14, 2025
RA Capital Management, L.P.
SCHEDULE 13G · filed Sep 30, 2026 · Common Stock, par value $0.0001 per share
Aberdeen Group plc
SCHEDULE 13G · filed Jan 16, 2026 · Common Stock, par value $0.0001 per share
Blackrock, Inc.
SCHEDULE 13G · filed Jul 27, 2026 · Common Stock · 2.9% in Jul 16, 2025
OrbiMed Capital LLC
SCHEDULE 13G/A · filed Feb 14, 2025 · Common Stock, par value $0.0001 per share
The Vanguard Group
SCHEDULE 13G/A · filed Jul 29, 2025 · Common Stock · reported falling below 5%
Citadel Securities LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, par value $0.0001 per share (the "Shares") · reported falling below 5%, from 5.3% in Nov 12, 2025
Octagon Capital Advisors LP
SCHEDULE 13G/A · filed May 14, 2026 · Common Stock, $0.0001 par value · reported falling below 5%, from 5.4% in Feb 10, 2026
What CRBP reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Jefferies LLC
An entity · legal entity · owns, named in the 10-K filed Mar 9, 2026
K2 HealthVentures LLC
An entity · legal entity · owns, named in the 10-K filed Mar 9, 2026
3 subsidiaries in 3 countries, from the list filed with the 10-K filed Mar 9, 2026.
Insider tradesForm 4
12sales
3purchases
8sales on a scheduled plan
8people selling
$600,000sold, in dollars
$100,000bought, in dollars
Open-market trades on Form 4 from Nov 2, 2025 to Nov 2, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 2, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window11 of 27 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 10% owner | 1 | $1.7M | 0 | 0 | $0 |
| Cohen Yuval | Chief Executive Officer | 2 | $300,000 | 2 | 0 | $0 |
| Chen Bihua | 10% owner | 1 | $300,000 | 0 | 0 | $0 |
| Moran Sean F. | Chief Financial Officer | 2 | $200,000 | 2 | 0 | $0 |
| Smethurst Dominic | Chief Medical Officer | 2 | $100,000 | 0 | 0 | $0 |
| Saxena Nishant C | Chief Business Officer | 0 | $0 | 0 | 3 | $100,000 |
| Hodgson Ian | Chief Operating Officer | 2 | $0 | 0 | 0 | $0 |
| Ben Yong | director | 1 | $0 | 1 | 0 | $0 |
| Altmeyer Anne | director | 1 | $0 | 1 | 0 | $0 |
| Jenkins John Kenneth | director | 1 | $0 | 1 | 0 | $0 |
| Kung Winston | director | 1 | $0 | 1 | 0 | $0 |